Natus Medical Incorporated (NASDAQ:BABY) Files An 8-K Results of Operations and Financial Condition
Item 2.02.
|
Results of Operations and Financial Condition
|
issuing a press release and holding a conference call regarding its
financial results for the first>quarter ended March 31,
2017>and other financial information. A copy of the press
release is furnished as Exhibit 99.1 to this Current Report on Form
8-K.
shall not be deemed filed for purposes of Section 18 of the
Securities Exchange Act of 1934 (the Exchange Act) or otherwise
subject to the liabilities of that Section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of
1933 or the Exchange Act, except as shall be expressly set forth by
specific reference in such a filing.
|
Item 9.01.
|
Financial Statements and Exhibits
|
|
Exhibit No.
|
|
Description
|
|
99.1
|
|
Press release dated April 26, 2017 describing the
Company’s results for its first quarter ended March 31, 2017 and other financial information. |
About Natus Medical Incorporated (NASDAQ:BABY)
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The Company’s segment is neurology and newborn care product families. Its product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It is organized into two strategic business units: Neurology and Newborn Care. Natus Medical Incorporated (NASDAQ:BABY) Recent Trading Information
Natus Medical Incorporated (NASDAQ:BABY) closed its last trading session down -0.20 at 40.40 with 373,056 shares trading hands.
